Haematological cancer affects more than 1.3 million people around the world annually and accounted for almost 800,000 deaths globally in 2020 [1, 2]. In the US more than 180,000 new haematological cancer cases (leukaemia, myeloma or lymphoma) were predicted in 2023, with approximately 1.6 million people living with a haematological cancer [3]. Similarly, in Australia this incidence has risen by nearly...

Denehy Linda et al.
BMC Cancer 2025; 25(1): 532
Lire la suite

The corona virus disease 2019 (COVID-19) was initially identified and then spread worldwide rapidly since December 2019, and it has become the largest global public health challenge to date. According to the World Health Organization, by March 2023, the number of confirmed cases of COVID-19 had reached 759 million worldwide, and the number of deaths had exceeded 6.8 million, seriously threatening human...

Zhuang Quan et al.
BMC Infectious Diseases 2025; 25(1): 426
Lire la suite

Allogeneic hematopoietic stem cell transplantation (aHSCT) is an important modality for treating hematologic malignancies as well as many non-malignant conditions in children and young adults. Pulmonary complications are relatively common after pediatric aHSCT and cause significant morbidity and mortality [1, 2, 3, 4–5]. Bronchiolitis obliterans, in which immune-mediated injury to the small-...

Gower William A. et al.
BMC Pediatrics 2025; 25(1): 250
Lire la suite